Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Heat shock protein family E (Hsp10) member 1 pseudogene 25 (HSPE1P25)** is a human pseudogene, meaning it is a non-protein-coding sequence derived from the heat shock protein family E (Hsp10) member 1 gene[1][5]. Pseudogenes like HSPE1P25 have accumulated disabling mutations and are not translated into functional proteins[4]. Generally considered genetically inactive, some pseudogenes in other contexts may play a regulatory role, such as acting as microRNA decoys, antisense RNAs, or contributing to gene expression modulation[2][4]. However, no direct biological function, disease role, or clinical relevance has been attributed to HSPE1P25 specifically. It is not considered a therapeutic target, receptor, or enzyme, and is not known to interact with drugs or serve as a biomarker[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein family E (Hsp10) member 1 pseudogene 25 (HSPE1P25).